Menu Search
Equities

InspireMD Inc

NSPR:NAQ

InspireMD Inc

Actions
Health CareMedical Equipment and Services
  • Price (USD)2.39
  • Today's Change-0.07 / -2.85%
  • Shares traded17.26k
  • 1 Year change-24.04%
  • Beta0.9340
Data delayed at least 15 minutes, as of Nov 12 2024 20:59 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in USDIncome statement in USDView more

Year on year InspireMD Inc had net income fall 7.71% from a loss of 18.49m to a larger loss of 19.92m despite a 20.00% increase in revenues from 5.17m to 6.21m. An increase in the selling, general and administrative costs as a percentage of sales from 232.45% to 241.24% was a component in the falling net income despite rising revenues.
Gross margin23.85%
Net profit margin-388.67%
Operating margin-412.99%
Return on assets-46.71%
Return on equity-54.55%
Return on investment-52.36%
More ▼

Cash flow in USDView more

In 2023, InspireMD Inc increased its cash reserves by 108.12%, or 5.01m. Cash Flow from Financing totalled 37.53m or 604.90% of revenues. In addition the company used 16.38m for operations while cash used for investing totalled 16.09m.
Cash flow per share-0.7339
Price/Cash flow per share--
Book value per share1.86
Tangible book value per share1.86
More ▼

Balance sheet in USDView more

InspireMD Inc has little financial risk as the capital structure does not rely on leverage.
Current ratio7.44
Quick ratio7.13
Total debt/total equity0.00
Total debt/total capital0.00
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.